Rybelsus and Wegovy both contain the active ingredient semaglutide. However, they serve different purposes: Rybelsus is used to treat type 2 diabetes in adults, while Wegovy is specifically approved for chronic weight management in certain adults and adolescents, administered as a weekly subcutaneous injection with more significant weight loss results .